Программа индивидуального визита профессора Хьюго Санера:
1 марта 2012 года
05.Встреча профессора. Заселение в гостинице «Урал».
Ответственная профессор
11. Экскурсия по ректорату ПГМА.
12.00-13.30 Встреча профессора Х. Санера с ректором ПГМА проф.
Вопросы для обсуждения:
1. Представление участников встречи (профессор и. н. рямзина). Приветствие ректора проф.
2. Краткая характеристика основных научных направлений - проректор по нир, профессор
3. Краткая характеристика международных связей академии – нач. Международного отдела
4. Ответное слово профессора Х. Санера. Обсуждение предложений по сотрудничеству.
13.30-14.30 Обед
14.30 – 15.15 Подготовка к лекции
15.15-17.30 Публичные лекции на темы:
1. «From Cardiac Rehabilitation to Cardiovascular Prevention»
2. «Cardiac Prevention in a Changing World»
17.30 – 18.00 Обсуждение вопросов развития науки и инноваций в Швейцарии. Вопросы по темам:«Применение информационных технологий в практике врача». «Предикторные системы в здравоохранении»
18.00-19.30 Ужин
19.30-21.00 Культурная программа
2 марта 2012 года
8.00-09.00 Посещение Центра здоровья на базе МУЗ «Городская клиническая поликлиника № 5» 6. Знакомство с организацией работы Центра.
09.00-10.30 Обсуждение проектов студентов, интернов, ординаторов. Обсуждение перспектив совместных научных исследований, создания малой инновационной группы.
Тема:
1. «Применение информационных технологий в практике врача».
2. «Предикторные системы в здравоохранении».
3. «Методы неинвазивной ранней диагностики сердечно-сосудистых заболеваний»
11.00 Отъезд в аэропорт профессора.
Информация о мероприятиях ведущего ученого, запланированных в рамках визита/Information about events in the frames of visit
Область наук, к которым относится научное исследование ведущего ученого/
Scientific field
Cardiovascular Prevention and Rehabilitation
Тема и название публичной лекции/Topic and name of public lecture
1. From Cardiac Rehabilitation to Cardiovascular Prevention
2. Cardiac Prevention in a Changing World
Краткое содержание публичной лекции/Content of public lecture
Cardiovascular disease (CVD) is the leading cause of death in most countries world-wide. Negative trends in lifestyle behavior such as decrease of physical activity, unhealthy nutrition habits, high smoking prevalence, and psychosocial stress contribute to this high mortality. Nevertheless, life expectancy has increased by 8 years in most countries of the Western world during the last 20 years; 6 years of these life years’ gain is due to a decrease of CVD. 48% of CVD mortality reduction since 1980 has come from reduction in smoking, 30% of reduction comes from secondary prevention and other primary prevention. Only 4 months of these 6 life years’ gains are due to interventional treatment. Challenges for CVD disease prevention and rehabilitation programs are a growing number of elderly, more fragile patients with co-morbidities, a growing number of younger patients with obesity, diabetes, and early stages of CVD and the need for CVD risk assessment clinics to detect subclinical disease before a first clinical event. Benefits of cardiac rehabilitation and secondary prevention programs include the reduction in overall and cardiovascular mortality by 25 – 50%, slowing of the atherosclerotic process, and decrease of rates of subsequent coronary events and re-hospitalizations. These benefits are thought to be mediated by several factors, including the physiological benefits of exercise training, psychological benefits of group support and counseling, improved adherence to preventive therapies, and improved control of cardiovascular risk factors. The scientific evidence behind the practice comes mainly from ambulatory cardiac rehabilitation programs lasting at least 8 – 12 weeks including preferably 36 sessions. Long-term adherence can be improved by long-term multifactorial continued education programs for lifestyle changes and pharmacological treatment. A multi-disciplinary team approach is essential for success. There are special groups with special needs including patients with heart failure, ICDs, elderly patients, and patients with grown-up congenital heart disease. Target systems of cardiovascular prevention and rehabilitation include the endothelium, the autonomous nervous system, the clotting coagulation system, and inflammation as the mediator of acute events. Lifestyle intervention programs have proven to favorably influence all of these factors which are also used as surrogate markers for increased cardiovascular risk. Cardiac rehabilitation in Europe shows a big variety of programs and service provision. A more evidence-based and structured way to offer cardiac rehabilitation in Europe is desirable. The Cardiac Rehabilitation Section is active to improve the situation in the framework of the European Association for Cardiovascular Prevention and Rehabilitation EACPR. Furthermore, ambulatory cardiac rehabilitation programs should evolve into preventive cardiology programs by integrating prevention and rehabilitation including patients with coronary heart disease, peripheral arterial disease, neurovascular disease, and diabetes. Such hospital-based prevention centers can relatively easy be integrated into existing hospital services.
